According to Reuters, British American Tobacco will be closing a cigarette manufacturing factory in Switzerland by 2023.
The closure will result in 226 workers being laid off. According to SwissInfo, the employees will receive "favorable social benefits.
BAT Switzerland has confirmed that it has made a final decision to transfer cigarette production from Boncourt to a larger factory in Europe and to close the Boncourt factory. This was stated in a press release by BAT.
Boncourt Mayor Lionel Maitre has expressed shock, disappointment, despair, and confusion over the closure of the factory, which will result in the town losing its biggest taxpayer.
Let's be clear - this is a heavy blow, but we will overcome it, and the situation is not entirely hopeless," said David Ere, the President of the Ruhr State government. "This decision forces us to face the painful consequences that we have been worried about.
In 2014, BAT shut down its research and development facility in Boncourt and laid off approximately 15 employees.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
